Results 141 to 150 of about 14,471,607 (152)
Some of the next articles are maybe not open access.
Oncology reports, 2005
Des-gamma-carboxyprothrombin (DCP), also known as a protein induced by vitamin K absence or antagonist II, is an abnormal prothrombin. The level of serum DCP is used in clinical diagnosis and prognosis of patients with hepatocellular carcinoma (HCC). Our previous immunohistochemical study showed that DCP is expressed not only in cancer tissues but also
Wei, Tang +9 more
openaire +1 more source
Des-gamma-carboxyprothrombin (DCP), also known as a protein induced by vitamin K absence or antagonist II, is an abnormal prothrombin. The level of serum DCP is used in clinical diagnosis and prognosis of patients with hepatocellular carcinoma (HCC). Our previous immunohistochemical study showed that DCP is expressed not only in cancer tissues but also
Wei, Tang +9 more
openaire +1 more source
Des-gamma-carboxyprothrombin activity in hepatocellular carcinoma
Journal of Hepatology, 1988openaire +1 more source
Hepato-gastroenterology, 1999
In the diagnosis of hepatocellular carcinoma (HCC), serum des-gamma-carboxyprothrombin (DCP) is a useful tumor marker. The conventional immunoassays for measurement of DCP levels, however, are not sensitive enough to detect small HCC. Therefore, we intended to elevate the minimal detection level of DCP by a modified enzyme linked immunosorbent assay ...
K, Soga +5 more
openaire +1 more source
In the diagnosis of hepatocellular carcinoma (HCC), serum des-gamma-carboxyprothrombin (DCP) is a useful tumor marker. The conventional immunoassays for measurement of DCP levels, however, are not sensitive enough to detect small HCC. Therefore, we intended to elevate the minimal detection level of DCP by a modified enzyme linked immunosorbent assay ...
K, Soga +5 more
openaire +1 more source
Des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosis
Journal of Digestive Diseases, 2011Yoshinori Inagaki +2 more
exaly

